Kobo Biotech Ltd
Kobo Biotech is engaged in the business of Pharmaceutical products.
- Market Cap ₹ 6.93 Cr.
- Current Price ₹ 2.91
- High / Low ₹ 6.01 / 2.35
- Stock P/E
- Book Value ₹ 23.6
- Dividend Yield 0.00 %
- ROCE -4.10 %
- ROE -49.4 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.12 times its book value
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -2.76% over last 3 years.
- Company has high debtors of 671 days.
- Working capital days have increased from 253 days to 534 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|
162 | 287 | 404 | 103 | |
133 | 238 | 361 | 104 | |
Operating Profit | 29 | 49 | 43 | -1 |
OPM % | 18% | 17% | 11% | -1% |
0 | 0 | 0 | 0 | |
Interest | 13 | 21 | 18 | 24 |
Depreciation | 6 | 11 | 10 | 10 |
Profit before tax | 10 | 18 | 15 | -34 |
Tax % | 0% | 11% | 8% | 2% |
10 | 16 | 14 | -35 | |
EPS in Rs | 4.37 | 6.72 | 6.22 | -15.48 |
Dividend Payout % | 23% | 15% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -14% |
TTM: | -74% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -355% |
Stock Price CAGR | |
---|---|
10 Years: | -14% |
5 Years: | 16% |
3 Years: | -15% |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -3% |
Last Year: | -49% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|
Equity Capital | 22 | 22 | 22 | 22 |
Reserves | 39 | 51 | 65 | 31 |
131 | 118 | 182 | 179 | |
57 | 154 | 142 | 163 | |
Total Liabilities | 250 | 346 | 412 | 396 |
110 | 100 | 108 | 104 | |
CWIP | 0 | 13 | 3 | 2 |
Investments | 0 | 0 | 0 | 0 |
140 | 232 | 301 | 290 | |
Total Assets | 250 | 346 | 412 | 396 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|
64 | 37 | 7 | ||
-14 | -7 | -5 | ||
-27 | -38 | -13 | ||
Net Cash Flow | 23 | -9 | -11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|
Debtor Days | 143 | 187 | 185 | 671 |
Inventory Days | 179 | 79 | 66 | 300 |
Days Payable | 115 | 203 | 111 | 468 |
Cash Conversion Cycle | 207 | 62 | 140 | 503 |
Working Capital Days | 195 | 88 | 137 | 534 |
ROCE % | 20% | 14% | -4% |
Documents
Announcements
-
Corporate Insolvency Resolution Process (CIRP)-List of Creditors
24h - Claims received and admitted during insolvency process.
-
Corporate Insolvency Resolution Process (CIRP)-Public Announcement
24h - Commencement of insolvency resolution for Kobo Biotech Limited.
-
Corporate Insolvency Resolution Process (CIRP)-Appointment of Interim Resolution Professional (IRP)
1d - Kobo Biotech Limited faces insolvency proceedings.
-
Corporate Insolvency Resolution Process (CIRP)-Initiation of Corporate Insolvency Resolution Process (CIRP) by Financial Creditors
1d - JM Financial seeks CIRP for Kobo Biotech due to default.
-
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
10 Oct - Second meeting of Committee of Creditors held.
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse